Li, M., Saviolakis, G. A., El‐Amin, W., Makhene, M. K., Osborn, B., Nedelman, J., . . . Everitt, D. (2020). Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers. Clin Pharmacol Drug Dev.
Citação norma ChicagoLi, Mengchun, George A. Saviolakis, Wael El‐Amin, Mamodikoe K. Makhene, Blaire Osborn, Jerry Nedelman, Tian J. Yang, and Daniel Everitt. "Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, On the QTc Interval in Healthy Volunteers." Clin Pharmacol Drug Dev 2020.
Citação norma MLALi, Mengchun, et al. "Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, On the QTc Interval in Healthy Volunteers." Clin Pharmacol Drug Dev 2020.